KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Finished Goods (2018 - 2021)

Historic Finished Goods for BioNTech SE (BNTX) over the last 4 years, with Q4 2021 value amounting to $194.1 million.

  • BioNTech SE's Finished Goods rose 4060568.61% to $194.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $194.1 million, marking a year-over-year increase of 4060568.61%. This contributed to the annual value of $194.1 million for FY2021, which is 4060568.61% up from last year.
  • Latest data reveals that BioNTech SE reported Finished Goods of $194.1 million as of Q4 2021, which was up 4060568.61% from $96.7 million recorded in Q2 2021.
  • BioNTech SE's 5-year Finished Goods high stood at $194.1 million for Q4 2021, and its period low was $476915.9 during Q4 2020.
  • For the 4-year period, BioNTech SE's Finished Goods averaged around $58.7 million, with its median value being $1.4 million (2018).
  • As far as peak fluctuations go, BioNTech SE's Finished Goods tumbled by 5025.43% in 2019, and later surged by 4060568.61% in 2021.
  • Quarter analysis of 4 years shows BioNTech SE's Finished Goods stood at $1.4 million in 2018, then tumbled by 50.25% to $700659.9 in 2019, then crashed by 31.93% to $476915.9 in 2020, then soared by 40605.69% to $194.1 million in 2021.
  • Its last three reported values are $194.1 million in Q4 2021, $96.7 million for Q2 2021, and $476915.9 during Q4 2020.